Skip to NavigationSkip to content

Pharmafile - Business Services News

Will reduce interest to 5.1% via a stake sale
The deal will see them utilising their drug discovery platform to develop five targeted cancer therapies.
Shares in trial-stage Celator Pharmaceuticals (Nasdaq: CPXX) soared gaining over four times in value as the company announced late-stage trials for...
Sees negative impact from “continued organizational distractions” in the quarter
Funds from stake sale to be used to continue drug trials
CEGX names new CEO, raises $21 million to drive product development
Indian arm of Pfizer ends production of cough drug Corex, shares slump
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches